Brain Targeted Delivery of Curcumin Using P80-PEG-Coated Poly(lactide-co-glycolide) Nanoparticles

Malay K. Das1,2,*, Kazim Husain3 and Yashwant Pathak1

1College of Pharmacy, University of South Florida, Tampa, Florida 33612, USA

2Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh-786 004, India

3H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA

*Corresponding author: Fax: +91 373 2370323; E-mail:


The low density lipoprotein (LDL) receptor has been shown to be upregulated in gliblastomamultiforme (GBM) tumor cells and is therefore a potential molecular target for the delivery of therapeutic agents. We prepared poly(lactide-co-glycolide) (PLGA) nanoparticles incorporating curcumin by nanoprecipitation technique with ultrasonication. The nanoparticles were found to be below 100 nm suitable for passive brain targeting to low density lipoprotein receptors overexpressed in gliblastomamultiforme tumor cells. The in vitro drug release study showed sustained drug delivery for 2 days with no initial burst release. The antitumor activity of the optimized nanoformulation was investigated in vitro by tumor cell uptake of curcumin loaded nanoparticles and further confirmed by cytotoxicity of U87MG brain tumor cells. The nanoparticles showed the higher cytotoxicity over pure drug due to their efficient internalization into the tumor cells. The surface coating with polysorbate 80 (P80) and poly(ethylene glycol) (PEG) showed the best antitumor activity. The results suggest that the poly(lactide-co-glycolide) nanoparticles incorporating curcumin had antitumor activity and are the promising system for brain tumor targeted drug delivery.


Curcumin, Poly (lactide-co-glycolide), P80, Brain targeted delivery

   View Article PDF File Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
  • Asian J. Chem. /
  •  2013 /
  •  25(Supplementary Issue) /
  •  pp S297-S301